Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Advaxis Inc (NASDAQ:ADXS)

15.11
Delayed Data
As of Aug 28
 +0.14 / +0.94%
Today’s Change
2.50
Today|||52-Week Range
30.13
+88.64%
Year-to-Date

Today’s Trading

Previous close14.97
Today’s open14.98
Day’s range14.53 - 15.59
Volume689,481
Average volume (3 months)1,463,258
Market cap$474.4M
Dividend yield--
Data as of 08/28/2015

Growth & Valuation

Earnings growth (last year)+76.34%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales54.40
Price/Book14.38

Competitors

 Today’s
change
Today’s
% change
PRTKParatek Pharmaceutic...+1.60+6.39%
ASNDAscendis Pharma A/S-0.88-4.39%
INFIInfinity Pharmaceuti...+0.16+1.75%
TBPHTheravance Biopharma...+0.87+6.33%
Data as of 08/28/2015

Financials

Next reporting dateSeptember 30, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$1.0M
Annual profit (last year)-$16.5M
Net profit margin-1,652.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. O'Connor
COO, Secretary, EVP &
Head-Investor Relations
Gregory T. Mayes
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers